New clue in dengue infection

A key step in how dengue virus invades mammalian cells has been uncovered, solving an ongoing conundrum and presenting a potential new drug target for a disease that infects up to 100 million people each year.

Dengue virus envelope
linkurl:David Goodsell, The Scripps Research Institute;http://commons.wikimedia.org/wiki/File:Dengue_envelope_1k4r.png

For years, researchers have struggled to fuse dengue virus with cell surfaces or even artificial membranes in the lab, preventing them from modeling how the virus -- for which there are currently no vaccines or effective medications -- infects cells. "Although the fusion step is required for dengue virus infection, this process is not completely understood," said linkurl:Rosa Maria del Angel;http://www.infectomica.cinvestav.mx/ in an email, a dengue researcher at the National Polytechnic Institute of Mexico who was not involved in the research. Now, linkurl:Leonid Chernomordik;http://www.nichd.nih.gov/about/staff/bio.cfm?nih_id=0010161111 and colleagues at the National Institutes of Health have pinpointed the source of the problem: Dengue requires an extra step to trigger fusion and infection. They published linkurl:their findings;http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1001131 online last week in PLoS Pathogens. Most mosquito and tick-borne viruses, including dengue, enter a cell though endocytosis. Once inside, the viral membrane fuses with the endosomal membrane to create a pore from which the viral genetic material escapes into the cytosol (see image below). Normally, a low pH environment within an endosome is sufficient to trigger fusion and the release of genetic material. But not for dengue virus -- a linkurl:2008 study;http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592694/?tool=pubmed using live-cell imaging found that dengue virus fuses membranes only after the endosome has traveled deep into the cell, long after a sufficiently low pH has been reached.

Dengue virus infects a cell
NIH

"They deserve a lot of credit for being creative and paying attention to this difference, which nobody else had really done," said linkurl:Margaret Kielian,;https://sites.google.com/site/kielianlab/contact-me a virologist at the Albert Einstein College of Medicine in New York, who was not involved in the research. "They've explained a discrepancy in the field."To identify the missing factor causing the late fusion, Chernomordik's team tagged dengue membranes with fluorescent probes, then watched for fusion with cell membranes and artificial membranes under various conditions. After years of testing, the team finally found the answer -- fusion occurs only when membranes are negatively charged, a condition present only in late endosomes. "It took quite a while to get there," laughed Chernomordik, "but the answer proved to be quite nicer than we expected." "It is really nice data that fits well with our previous results," linkurl:Jolanda Smit;http://www.rug.nl/staff/jolanda.smit/index of the University of Groningen, author of the 2008 live-cell tracking paper, wrote in an email to The Scientist. The virus may have evolved the strategy to prevent premature release of its genetic material, said Chernomordik, timing the release until the endosome is deep within the cell, close to the replication machinery.The new information provides a target for future therapies to disrupt fusion as well as a needed recipe for fusion in the laboratory, added Chernomordik. Using negatively charged membranes, researchers can now model fusion in the laboratory and test new antivirals to see which of them disrupts fusion, possibly preventing dengue infection. "We now have an assay which is simple and straight-forward," said Chernomordik. "We're now in a position to screen different antivirals."Zaitseva, E. et al., "Dengue Virus Ensures Its Fusion in Late Endosomes Using Compartment-Specific Lipids," PLoS Pathogens, 6:e1001131- 2010.
**__Related stories:__***linkurl:A new path for HIV entry;http://www.the-scientist.com/blog/display/55670/
[30th April 2009] *linkurl:Structure hints at Ebola's cunning;http://www.the-scientist.com/blog/display/54827/
[9th July 2008] *linkurl:New clues to flavivirus replication;http://www.the-scientist.com/news/display/24211/
[1st August 2006]

New clue in dengue infection

The Scientist ARCHIVES

Become a Member of

Meet the Author

Megan Scudellari

Related Research Resources

What Is the Amniotic Fluid Composed of?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform